Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-22-012951

CFO acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Horn Howard CFO 2022-02-22 Grant or award +35,000 235,384 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Horn Howard CFO 2022-02-22 Grant or award · Stock Option (Right to Buy) +50,000 50,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…